ES2067744T3 - Aminas heterociclicas con actividad sobre el sistema nervioso central. - Google Patents
Aminas heterociclicas con actividad sobre el sistema nervioso central.Info
- Publication number
- ES2067744T3 ES2067744T3 ES90908816T ES90908816T ES2067744T3 ES 2067744 T3 ES2067744 T3 ES 2067744T3 ES 90908816 T ES90908816 T ES 90908816T ES 90908816 T ES90908816 T ES 90908816T ES 2067744 T3 ES2067744 T3 ES 2067744T3
- Authority
- ES
- Spain
- Prior art keywords
- nervous system
- central nervous
- activity
- compounds
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
COMPUESTOS CONTENIENDO NITROGENO TRICICLICO, CON ACTIVIDAD EN EL SISTEMA NERVIOSO CENTRAL DE FORMULA ESTRUCTURAL (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, DONDE R SUB 1, R SUB 2 Y R SUB 3 SON INDEPENDIENTEMENTE HIDROGENO, ALQUILO C SUB 1-6, ALQUENILO O ALQUINILO, CICLOALQUILO C SUB 3-10, O R SUB 1 Y R SUB 2 SE UNEN PARA FORMAR UNA AMINA CICLICA C SUB 3-7 QUE PUEDE CONTENER HETEROATOMOS ADICIONALES; X ES HIDROGENO, ALQUILO C SUB 1-6, HALOGENO, HIDROXI, ALCOXI, CIANO, CARBOXAMIDA, CARBOXILO, O CARBOALCOXILO; A ES SO SUB 2, N, CH, CH SUB 2, CHCH SUB 3, C = O, C = S, C-SCH SUB 3, C = NH, C-NH SUB 2, C-NHCH SUB 3, C-NHCOOCH SUB 3, O C-NHCN; B ES CH SUB 2, CH, C = O, N, NH O N-CH SUB 3; N ES 0 O 1; Y D ES CH, CH SUB 2, C = O, O, N, NH O N-CH SUB 3. ESTOS NUEVOS COMPUESTOS SON APROPIADOS PARA TRATAR LA ESQUIZOFRENIA, ENFERMEDAD DE PARKINSON, ANSIEDAD, DEPRESION O COMO COMPUESTOS PARA BAJAR LA PRESION SANGUINEA EN ANIMALES O RECEPTORES HUMANOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36437489A | 1989-06-09 | 1989-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2067744T3 true ES2067744T3 (es) | 1995-04-01 |
Family
ID=23434241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90908816T Expired - Lifetime ES2067744T3 (es) | 1989-06-09 | 1990-05-15 | Aminas heterociclicas con actividad sobre el sistema nervioso central. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0480939B1 (es) |
JP (1) | JP2955358B2 (es) |
KR (1) | KR0167346B1 (es) |
AT (1) | ATE117688T1 (es) |
AU (1) | AU626427B2 (es) |
CA (1) | CA2051697C (es) |
DE (1) | DE69016430T2 (es) |
DK (1) | DK0480939T3 (es) |
ES (1) | ES2067744T3 (es) |
FI (2) | FI96310C (es) |
HK (1) | HK65397A (es) |
HU (2) | HU210264B (es) |
NO (1) | NO301421B1 (es) |
RU (1) | RU2023712C1 (es) |
WO (1) | WO1990015058A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05117276A (ja) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | 新規な3環性キノキサリンジオン誘導体 |
TW260660B (es) * | 1993-04-22 | 1995-10-21 | Sumitomo Pharma | |
DE4314593A1 (de) * | 1993-04-28 | 1994-11-03 | Schering Ag | Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln |
ATE159943T1 (de) * | 1993-07-27 | 1997-11-15 | Upjohn Co | Heterozyclische amine mit zns-wirksamkeit |
FR2719843B1 (fr) * | 1994-05-10 | 1996-06-07 | Synthelabo | Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique. |
EP0705834A1 (de) * | 1994-07-27 | 1996-04-10 | Ciba-Geigy Ag | Azaaliphatisch Überbrückte Chinoxalin-2,3-dione |
EP0705835A1 (de) * | 1994-09-01 | 1996-04-10 | Ciba-Geigy Ag | Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione |
ES2193255T3 (es) * | 1995-08-10 | 2003-11-01 | Bayer Cropscience Ag | Halogenobencimidazoles y su empleo como microibicidas. |
US6288075B1 (en) | 1998-02-26 | 2001-09-11 | Rhone-Poulenc Rorer S.A. | Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same |
FR2760237B1 (fr) * | 1997-02-28 | 1999-04-16 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
US6197339B1 (en) * | 1997-09-30 | 2001-03-06 | Pharmacia & Upjohn Company | Sustained release tablet formulation to treat Parkinson's disease |
US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
AU767089B2 (en) * | 1999-02-05 | 2003-10-30 | Pharmacia & Upjohn Company | Process to prepare (5R)-(methylamino)-5,6-dihydro-4H- imidazo(4,5,1-ij)-quinolin-2(1H)-one |
US7074927B2 (en) | 1999-05-13 | 2006-07-11 | Pharmacia & Upjohn Company | Heterocyclic amines having central nervous system activity |
DE19954707A1 (de) * | 1999-11-13 | 2001-05-17 | Merck Patent Gmbh | Imidazolverbindungen als Phosphodiesterase VII-Hemmer |
GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
NZ531171A (en) | 2000-04-21 | 2005-03-24 | Upjohn Co | Cabergoline-type compounds for treating fibromyalgia and chronic fatigue syndrome |
AR033520A1 (es) * | 2000-04-27 | 2003-12-26 | Upjohn Co | (5r)-(metilamino) -5,6-dihidro-4h-imidazo[4,5,1-ij] quinolin-2(1h)-tiona |
AU2001283393B2 (en) | 2000-08-16 | 2005-09-22 | Pharmacia & Upjohn Company | Compounds for the treatment of addictive disorders |
US6759405B2 (en) | 2000-11-03 | 2004-07-06 | Wyeth | Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
AR031202A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados |
US6858604B2 (en) | 2000-11-03 | 2005-02-22 | Wyeth | Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
FR2825705B1 (fr) | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
TWI312781B (en) | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
TW200307682A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
TW200307540A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
MY136318A (en) * | 2002-07-25 | 2008-09-30 | Pharmacia Corp | Sustained-release tablet composition |
US20050079217A1 (en) * | 2002-07-25 | 2005-04-14 | Ganorkar Loksidh D. | Sustained-release tablet composition comprising a dopamine receptor agonist |
US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
WO2004037971A2 (en) * | 2002-10-25 | 2004-05-06 | Pharmacia & Upjohn Company Llc | Use of heterocyclic amine-type compounds as neuroprotective agents |
JP2007500728A (ja) * | 2003-07-31 | 2007-01-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Pdfインヒビターとしての二環式化合物および組成物 |
WO2005051488A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Combination of dopamine agonists and monoamine reuptake inhibitors |
BRPI0513846A (pt) | 2004-08-13 | 2008-05-20 | Boehringer Ingelheim Int | formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo |
EP2431026A1 (en) | 2004-08-13 | 2012-03-21 | Boehringer Ingelheim International GmbH | Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
AR052227A1 (es) * | 2004-11-05 | 2007-03-07 | Wyeth Corp | Metabolitos derivados de [1,4] diazepin [ 6,7,1-ij] quinolina, metodos de preparacion y usos de los mismos |
GT200500317A (es) | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
CA2609562A1 (en) | 2005-06-14 | 2006-12-28 | Schering Corporation | Macrocyclic heterocyclic aspartyl protease inhibitors |
AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
US20140080813A1 (en) | 2012-09-14 | 2014-03-20 | AbbVie Deutschland GmbH & Co. KG | Tricyclic quinoline and quinoxaline derivatives |
CA2884548A1 (en) | 2012-09-14 | 2014-03-20 | AbbVie Deutschland GmbH & Co. KG | Tricyclic quinoline and quinoxaline derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900701260A (ko) * | 1988-05-09 | 1990-12-01 | 로버트 에이. 아미테이지 | 2,3-디하이드로-1h-페날렌-2-아민 불안해소/우울증 방지제 |
-
1990
- 1990-05-15 JP JP2508489A patent/JP2955358B2/ja not_active Expired - Fee Related
- 1990-05-15 WO PCT/US1990/002621 patent/WO1990015058A1/en active IP Right Grant
- 1990-05-15 CA CA002051697A patent/CA2051697C/en not_active Expired - Fee Related
- 1990-05-15 AT AT90908816T patent/ATE117688T1/de not_active IP Right Cessation
- 1990-05-15 ES ES90908816T patent/ES2067744T3/es not_active Expired - Lifetime
- 1990-05-15 DE DE69016430T patent/DE69016430T2/de not_active Expired - Fee Related
- 1990-05-15 KR KR1019910701790A patent/KR0167346B1/ko not_active IP Right Cessation
- 1990-05-15 AU AU57438/90A patent/AU626427B2/en not_active Ceased
- 1990-05-15 DK DK90908816.3T patent/DK0480939T3/da active
- 1990-05-15 EP EP90908816A patent/EP0480939B1/en not_active Expired - Lifetime
- 1990-05-15 HU HU905216A patent/HU210264B/hu not_active IP Right Cessation
-
1991
- 1991-12-04 FI FI915715A patent/FI96310C/fi active
- 1991-12-06 NO NO914827A patent/NO301421B1/no unknown
- 1991-12-06 RU SU915010471A patent/RU2023712C1/ru not_active IP Right Cessation
-
1994
- 1994-10-07 FI FI944704A patent/FI96687C/fi active
-
1995
- 1995-06-30 HU HU95P/P00660P patent/HU211702A9/hu unknown
-
1997
- 1997-05-15 HK HK65397A patent/HK65397A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HU211702A9 (en) | 1995-12-28 |
DE69016430D1 (de) | 1995-03-09 |
WO1990015058A1 (en) | 1990-12-13 |
FI96687B (fi) | 1996-04-30 |
HU210264B (en) | 1995-03-28 |
AU5743890A (en) | 1991-01-07 |
AU626427B2 (en) | 1992-07-30 |
JPH04506071A (ja) | 1992-10-22 |
EP0480939A1 (en) | 1992-04-22 |
FI96310C (fi) | 1996-06-10 |
KR920701204A (ko) | 1992-08-11 |
NO914827L (no) | 1992-02-07 |
HU905216D0 (en) | 1992-02-28 |
RU2023712C1 (ru) | 1994-11-30 |
CA2051697A1 (en) | 1990-12-10 |
DE69016430T2 (de) | 1995-06-01 |
CA2051697C (en) | 1996-10-08 |
NO914827D0 (no) | 1991-12-06 |
FI944704A0 (fi) | 1994-10-07 |
FI96687C (fi) | 1996-08-12 |
FI96310B (fi) | 1996-02-29 |
KR0167346B1 (ko) | 1999-01-15 |
EP0480939B1 (en) | 1995-01-25 |
HUT60269A (en) | 1992-08-28 |
ATE117688T1 (de) | 1995-02-15 |
FI944704A (fi) | 1994-10-07 |
HK65397A (en) | 1997-05-23 |
JP2955358B2 (ja) | 1999-10-04 |
NO301421B1 (no) | 1997-10-27 |
DK0480939T3 (da) | 1995-07-10 |
FI915715A0 (fi) | 1991-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2067744T3 (es) | Aminas heterociclicas con actividad sobre el sistema nervioso central. | |
FI102175B (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten v almistamiseksi | |
DE3681517D1 (de) | Thiazolidinderivate, verfahren zu deren herstellung und deren anwendung. | |
PE20001467A1 (es) | Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina | |
MC2195A1 (fr) | Derives d'acides amines | |
PE20040522A1 (es) | Derivados de diarilurea dependientes de la cinasa de proteina | |
AR047557A1 (es) | Compuestos derivados de piridazina y su uso como agentes terapeuticos | |
DK0632036T3 (da) | Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser | |
NO910860D0 (no) | Fremgangsmaate for fremstilling av azabicyklo- og azacyklo-oksiner og -aminer. | |
FR2581063B1 (fr) | Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique | |
YU46706B (sh) | Postupak za dobijanje amidnih jedinjenja | |
ATE101040T1 (de) | Derivate und analoge von pyrimidon zur behandlung von asthma und bestimmte hautkrankheiten. | |
KR900012893A (ko) | 치환된-아세트 아미드 화합물 및 그 제조방법 | |
KR920701122A (ko) | 신규 이환식 아미노-치환 화합물 | |
DE69315363D1 (de) | Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel | |
DK249288D0 (da) | Substituerede silylalkylenaminer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
ATE250413T1 (de) | 2-aminotetraline zur behandlung von glaukom | |
KR900003141A (ko) | 신규한 벤즈아졸 유도체, 이의 제조방법과 이러한 화합물들을 함유하는 약학적 제제 및 이의 용도 | |
KR920011491A (ko) | 헥사히드로-8-히드록시-2, 6-메타노-2h-퀴놀리진-3(4h)-온 및 관련 화합물의 특정 에스테르를 함유하는 인식 장애 치료용 제약 조성물 | |
ES8605265A1 (es) | Procedimiento para la obtencion de la 8-(4-(4-(2-pirimidi- nil)-1-piperazinil)butil)-8-azaspiro(4,5)decano-7,9-diona y su clorhidrato | |
DE3772764D1 (de) | Anwendung von n-((1-aethyl-2-pyrrolidinyl)methyl)-methoxy-5-sulfamoylbenzamid zur sterilitaetsbehandlung. | |
BRPI0417241A (pt) | agente e processo para a prevenção e/ou para o tratamento de disfunção do cérebro superior, e, uso de um derivado de xantina, ou um sal farmaceuticamente aceitável do mesmo | |
DE69010606D1 (de) | 3-Isoxazolonderivate, ihre Herstellung und ihre Anwendung in der Therapeutik. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 480939 Country of ref document: ES |